Editorial: Precision oncology: integrating molecular mechanisms, organoid models, and omics technologies for personalized cancer care - Takeaways - MDSpire

Editorial: Precision oncology: integrating molecular mechanisms, organoid models, and omics technologies for personalized cancer care

  • By

  • Muharrem Okan Cakir

  • Betul Karademir-Yilmaz

  • G. Hossein Ashrafi

  • Mustafa Özdoğan

  • June 22, 2026

  • 0 min

Share

  • 1

    Precision oncology is evolving to integrate molecular mechanisms, multi-omics technologies, and functional disease models for personalized cancer care.

  • 2

    Cancer is viewed as a dynamic biological system influenced by genetic alterations, epigenetic changes, and microenvironmental factors.

  • 3

    Omics-driven classification and biomarker discovery are crucial for understanding both common and rare molecular contexts in cancer.

  • 4

    Functional modeling, including patient-derived organoids, enhances drug development and therapeutic decision-making in precision oncology.

  • 5

    A comprehensive approach to precision oncology requires integrating diagnostic tools, clinical context, and inclusive trial designs.

Original Source(s)

Editorial: Precision oncology: integrating molecular mechanisms, organoid models, and omics technologies for personalized cancer care

  • by Muharrem Okan Cakir, Betul Karademir-Yilmaz, G. Hossein Ashrafi, Mustafa Özdoğan

  • June 22, 2026

Related Content

PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses

Case Report: Exchange transfusion for hemolytic anemia and acute kidney injury associated with hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin in a patient with hepatocellular carcinoma

Past present and future of radiosensitization in cervical cancer